Definium Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Definium Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($67.27M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($42.74M) | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($23.35M) | May 8, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($13.68M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($5.85M) | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($54.40M) | May 8, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($17.92M) | Nov 7, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($29.13M) | Aug 13, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($24.82M) | May 8, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($16.49M) | Nov 2, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($16.96M) | Aug 3, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($18.45M) | May 4, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($17.20M) | Nov 10, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($45.25M) | Aug 11, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($13.76M) | May 16, 2022 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($45.67M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($40.90M) | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($32.16M) | May 8, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($24.79M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($24.46M) | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($22.20M) | May 8, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($21.62M) | Nov 7, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($29.18M) | Aug 13, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($20.86M) | May 8, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($16.98M) | Nov 2, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($16.94M) | Aug 3, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($18.51M) | May 4, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($17.23M) | Nov 10, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($45.22M) | Aug 11, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($13.85M) | May 16, 2022 |